Fontani Vania, Rinaldi Arianna, Rinaldi Salvatore
Department of Regenerative Medicine, Rinaldi Fontani Institute, Florence, ITA.
Department of Adaptive Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, ITA.
Cureus. 2024 Nov 22;16(11):e74197. doi: 10.7759/cureus.74197. eCollection 2024 Nov.
This case report presents the use of radio electric asymmetric conveyer (REAC) neuroregenerative (RGN-N) therapy in a pediatric patient with adrenoleukodystrophy (ALD), a progressive neurodegenerative disorder with limited therapeutic options. The patient underwent three REAC RGN-N treatment cycles, each lasting 72 hours, with approximately 6-7 hours of daily sessions. An asymmetric conveyor probe (ACP) was positioned along the spine to channel the interaction of the emitted radio electric field with cellular electro-metabolic alterations, promoting progressive bioelectrical restoration. The treatment parameters were pre-set on the REAC device (BENE 110, ASMED, Scandicci, Italy) and could not be altered by the operator, ensuring consistent therapeutic delivery. Significant functional improvements were observed across the motor, cognitive, and swallowing domains, as assessed by standardized scales. This report aligns with preclinical studies on REAC technology's potential for neuroregeneration and suggests REAC RGN-N therapy as a promising adjunctive intervention in ALD management.
本病例报告介绍了在一名患有肾上腺脑白质营养不良（ALD）的儿科患者中使用射频电不对称输送器（REAC）神经再生（RGN - N）疗法的情况，ALD是一种治疗选择有限的进行性神经退行性疾病。该患者接受了三个REAC RGN - N治疗周期，每个周期持续72小时，每天治疗约6 - 7小时。一个不对称输送器探头（ACP）沿着脊柱放置，以引导发射的射频电场与细胞电代谢改变之间的相互作用，促进渐进性生物电恢复。治疗参数在REAC设备（BENE 110，ASMED，意大利斯坎迪奇）上预先设定，操作员无法更改，以确保治疗传递的一致性。通过标准化量表评估，在运动、认知和吞咽领域观察到了显著的功能改善。本报告与关于REAC技术神经再生潜力的临床前研究一致，并表明REAC RGN - N疗法是ALD管理中有前景的辅助干预措施。
